JHSY(002597)
Search documents
金禾实业(002597) - 2017年8月30日投资者关系活动记录表
2022-12-05 01:46
安徽金禾实业股份有限公司投资者活动记录 证券代码:002597 证券简称:金禾实业 安徽金禾实业股份有限公司 投资者关系活动记录表 编号:2017-002 | --- | --- | --- | --- | --- | --- | --- | |----------------|---------------------------|---------------------------------------------------------------------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | | | | | 类别 | □ | 媒体采访 □业绩说明会 | | | | | | | □ | 新闻发布会 □路演活动 | | | | | | | □ 现场参观 | | | | | | | | ■其他 ( 201 ...
金禾实业(002597) - 2017年12月1日投资者关系活动记录表
2022-12-04 08:20
证券代码:002597 证券简称:金禾实业 编号:2017003 安徽金禾实业股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------|----------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------| | | □ | 特定对象调研 □分析师会议 | | 投资者关系 | □媒体采访 □业绩说明会 | | | 活动类别 | □ 新闻发布会 □路演活动 | | | | ■现场调研 | □ 其他(请文字说明其他活动内容) | | 参与单位名 | 海通证券食品饮料行业研究员 海证券研究所 研究总监 | 成珊、中银国际 刘航、华富基金研究员 黄嗣杰、国 代鹏举、国海证券研究所 化工及新材料行业分析师 谷 | | 称及人员姓 | 航、华商基金 投资经理 应超、北京优素投 ...
金禾实业(002597) - 2018年8月15日投资者关系活动记录表
2022-12-03 09:22
编号:2018001 证券代码:002597 证券简称:金禾实业 安徽金禾实业股份有限公司 投资者关系活动记录表 | --- | --- | --- | |---------------------|------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | □ | 特定对象调研 ■分析师会议 | | 投资者关系 | □媒体采访 □业绩说明会 | | | 活动类别 | □ 新闻发布会 □路演活动 | | | | □现场调研 | □ 其他(请文字说明其他活动内容) | | 参与单位名 | 申万化工行业首席研究员 海电器集团财务有限责任公司 | 宋涛、上海悦苏资管 李金伟、上海理成资产 ...
金禾实业(002597) - 2018年12月11日投资者关系活动记录表
2022-12-03 09:11
编号:2018002 证券代码:002597 证券简称:金禾实业 安徽金禾实业股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------|-----------------------|-----------------------------------------------------------------| | | □ | 特定对象调研 □分析师会议 | | 投资者关系 | □媒体采访 □业绩说明会 | | | 活动类别 | □ | 新闻发布会 □路演活动 | | | ■现场调研 | □ 其他(请文字说明其他活动内容) | | 参与单位名 | | 中银基金 刘航 鞠龙;中欧基金 王习;正植投资 项敬康 叶正松;招商 | | 称及人员姓 | | 证券 周铮;英大保险 徐文浩;银华基金 罗婷;银河基金 姚雯薏;兴 | | 名 | | 证资管 卓佳亮;西南证券 黄景文;沃胜资产 魏延军;泰达宏利 杨楠 | | | | 森;太平资产 徐劭冉;太平养老 郭建奇;太平洋证券 柳强;双安资 | | | | 产 李随军;申万菱信 廖明兵;申万宏源 沈衡;融通基金 李文海; ...
金禾实业(002597) - 2021年5月6日投资者关系活动记录表
2022-11-22 02:56
编号:2021-002 证券代码:002597 证券简称:金禾实业 安徽金禾实业股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------------|--------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------| | 投资者关系活动 \n类别 \n | 特定对象调研 □分析师会议 \n□媒体采访 □业绩说明会 \n□新闻发布会 \n 现场参观 \n□其他 | □路演活动 | | 参与单位名称及 | 1 、长江证券 施航、张俊 | 2、南方基金 都逸敏 | | 人员姓名 | 3 、富安达基金 | 栾庆帅 4、华安证券 刘万鹏、曾祥钊 | | | 5 、天风证券 唐婕、沈诗韵 | 6 、博远基金 潘俊伊 | | | 7 、前海人寿 | 贾宇博 8、中 ...
金禾实业(002597) - 2022 Q3 - 季度财报
2022-10-17 16:00
Financial Performance - The company's operating revenue for Q3 2022 reached ¥1,928,046,239.09, an increase of 24.80% year-on-year, while the total revenue for the year-to-date was ¥5,528,377,869.21, up 37.54% compared to the same period last year[6]. - Net profit attributable to shareholders for Q3 2022 was ¥478,893,706.13, representing a significant increase of 74.72% year-on-year, with a year-to-date net profit of ¥1,332,560,950.56, up 86.79%[6]. - The net profit after deducting non-recurring gains and losses for Q3 2022 was ¥458,681,820.79, a remarkable increase of 105.91% year-on-year, while the year-to-date figure was ¥1,338,835,648.79, up 126.39%[6]. - Basic earnings per share for Q3 2022 were ¥0.85, an increase of 73.47% year-on-year, while diluted earnings per share were ¥0.83, up 72.92%[6]. - The net profit for the current period is approximately ¥1.33 billion, an increase of 86.9% compared to ¥712.95 million in the previous period[37]. - The total comprehensive income for the current period is approximately ¥1.34 billion, compared to ¥712.89 million in the previous period, reflecting a significant growth[40]. - Basic earnings per share increased to ¥2.38 from ¥1.27, representing a growth of 87.6%[40]. - The company reported a significant increase in sales revenue, with cash received from sales reaching ¥5.76 billion, compared to ¥4.07 billion in the previous period[41]. - The company’s total profit for the current period is approximately ¥1.57 billion, compared to ¥854.38 million in the previous period, marking an increase of 84.5%[37]. Cash Flow and Assets - The company's cash flow from operating activities for the year-to-date was ¥1,482,862,453.20, reflecting a substantial increase of 159.28% compared to the same period last year[6]. - Cash flow from operating activities generated ¥5.57 billion, up from ¥4.04 billion, indicating a growth of 37.8%[41]. - The net cash flow from operating activities is ¥1.48 billion, compared to ¥571.91 million in the previous period, showing a substantial increase[41]. - Cash and cash equivalents at the end of the period totaled approximately ¥1.29 billion, an increase from ¥844.67 million at the end of the previous period[44]. - The company's cash and cash equivalents as of September 30, 2022, amounted to RMB 2,542,267,351.87, an increase from RMB 1,985,105,930.23 at the beginning of the year[27]. - Total assets as of September 30, 2022, amounted to ¥10,043,893,571.14, representing a 13.52% increase from the end of the previous year[6]. - The total assets increased to ¥10,043,893,571.14, up from ¥8,847,824,127.36, representing a growth of 13.5%[33]. - Total current assets reached RMB 6,539,212,386.13, compared to RMB 5,493,948,776.20 at the start of the year[27]. Shareholder Information - Total number of common shareholders at the end of the reporting period was 27,205[16]. - The largest shareholder, Anhui Jinrui Investment Group Co., Ltd., holds 44.66% with 250,487,223 shares, which are pledged[21]. - The company's equity attributable to shareholders was ¥6,637,697,918.25, up 13.64% from the end of the previous year[6]. - The company's total equity reached ¥6,638,598,386.52, compared to ¥5,841,117,492.03, marking an increase of 13.6%[33]. Operational Highlights - Accounts receivable increased by 77.49% to ¥896,621,103.28, primarily due to increased operating revenue and uncollected payments from power generation business[11]. - Inventory levels rose by 30.35% to ¥659,226,430.08, attributed to increased overall production capacity[11]. - Research and development expenses were ¥167,628,721.18, compared to ¥146,536,333.46, indicating a rise of 14.4% year-over-year[34]. - Operating costs amounted to ¥3,916,180,096.12, up from ¥3,290,362,008.00, reflecting a year-over-year increase of 19.0%[34]. - The company faced a patent investigation by Celanese regarding its sweetener products, which concluded without finding any infringement[26]. Future Outlook and Plans - Future outlook includes continued investment in R&D and potential market expansion strategies to sustain growth momentum[34]. - The company plans to implement a restricted stock incentive plan and an employee stock ownership plan to attract and retain talent[23]. - The company has completed the election of the sixth board of directors and supervisory board[23]. Government Support - The company received government subsidies amounting to ¥43,926,085.94, a 95.63% increase compared to the previous year, contributing positively to other income[15].
金禾实业(002597) - 关于参加安徽辖区上市公司2022年投资者网上集体接待日活动的公告
2022-09-02 08:43
证券代码:002597 证券简称:金禾实业 公告编号:2022-064 安徽金禾实业股份有限公司 关于参加安徽辖区上市公司 2022 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,安徽金禾实业股份有限公司(以下简称"公司" 或"本公司")将参加由安徽证监局指导、安徽上市公司协会与深圳市全景网络有限公 司联合举办的"2022 年安徽辖区上市公司投资者集体接待日活动",现将相关事项公告 如下: 本次活动将采用网络远程的方式举行,投资者可登录"全景路演"网站 (http://rs.p5w.net),或关注微信公众号:全景财经,或下载全景路演 APP,参与本 次互动交流,活动时间为 2022 年 9 月 7 日(周三)16:00-17:30。届时公司高管将在 线就公司 2022 年半年度报告中的公司业绩、公司治理、发展战略、经营状况和可持续 发展等投资者关心的问题,与投资者进行沟通与交流,欢迎广大投资者踊跃参与。 特此公告。 安徽金禾实业股份有限公司 董事会 二〇二二年九月三日 ...
金禾实业(002597) - 2022 Q2 - 季度财报
2022-08-25 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was CNY 3,600,331,630.12, representing a 45.50% increase compared to CNY 2,474,389,399.24 in the same period last year[26]. - The net profit attributable to shareholders for the same period was CNY 853,667,244.43, a 94.32% increase from CNY 439,316,436.14 year-on-year[26]. - The net profit excluding non-recurring gains and losses reached CNY 880,153,828.00, up 138.77% from CNY 368,620,122.93 in the previous year[26]. - The net cash flow from operating activities was CNY 921,718,461.37, showing a significant increase of 230.17% compared to CNY 279,162,464.39 in the same period last year[26]. - Basic earnings per share rose to CNY 1.53, a 96.15% increase from CNY 0.78 in the previous year[26]. - Diluted earnings per share increased to CNY 1.48, up 92.21% from CNY 0.77 year-on-year[26]. - The total assets at the end of the reporting period were CNY 9,837,541,549.53, an increase of 11.19% from CNY 8,847,824,127.36 at the end of the previous year[26]. - The net assets attributable to shareholders reached CNY 6,200,248,095.69, reflecting a 6.15% increase from CNY 5,840,834,086.67 at the end of the previous year[26]. - The weighted average return on net assets was 14.01%, up from 8.72% in the previous year, an increase of 5.29 percentage points[26]. Revenue and Cost Analysis - The operating cost increased to ¥2,343,188,913.77, a rise of 28.29% from ¥1,826,410,676.44, in line with the increase in operating revenue[54]. - The gross profit margin for the food manufacturing segment was 43.60%, with operating revenue increasing by 85.19% to ¥2,220,085,799.53[57]. - The company reported a significant increase in foreign sales, which rose by 66.43% to ¥1,210,437,364.09, compared to ¥727,316,746.77 in the previous year[57]. Research and Development - The company continues to focus on R&D investments to enhance core competitiveness and reduce production costs[41]. - Research and development investment amounted to ¥106,792,437.33, reflecting a growth of 19.12% from ¥89,653,308.52 in the previous year[54]. - The company obtained 42 authorized patents from January 1, 2022, to June 30, 2022, including 36 invention patents and 6 utility model patents, totaling 201 authorized patents as of June 30, 2022[42]. Environmental and Safety Management - The company has established a comprehensive environmental protection and governance system, ensuring compliance with emission standards for waste discharge[101]. - The company operates four wastewater treatment facilities with a total capacity of 12,600 tons per day, effectively treating wastewater to meet local discharge standards[102]. - The company has over 80 waste gas treatment devices, significantly enhancing its ability to manage emissions and ensuring compliance with environmental regulations[106]. - The company has implemented an environmental self-monitoring plan in compliance with relevant laws and regulations, and has signed contracts with third-party testing agencies for continuous monitoring of wastewater, waste gas, and noise emissions[109]. - The company has conducted multiple emergency response drills for environmental incidents, refining its emergency measures based on the outcomes[108]. Shareholder and Equity Information - The company plans not to distribute cash dividends or issue bonus shares for the half-year period, nor to increase share capital from capital reserves[92]. - The company repurchased 3,831,711 shares, representing 0.68% of the total share capital, with a total transaction amount of 149,195,849.95 yuan[155]. - The total number of shares held by the top ten unrestricted shareholders is 250,487,233 shares[176]. - The total number of common shareholders at the end of the reporting period was 27,790[171]. - Anhui Jinrui Investment Group holds 44.66% of the shares, totaling 250,487,223 shares, with 28,500,000 shares pledged[171]. Risks and Challenges - The company faces environmental governance risks due to stricter regulations, which may increase costs and impact performance if compliance is not met[78]. - The company is exposed to safety production risks associated with hazardous chemicals, despite having safety measures and protocols in place[79]. - The company is vulnerable to macroeconomic fluctuations that could affect demand for its bulk chemical products, potentially impacting sales and performance[80]. - The company faces increased risks in export development due to the ongoing COVID-19 pandemic, trade protectionism, and geopolitical tensions, impacting sales of food additives and functional chemical products[81]. Strategic Initiatives - The company has established a comprehensive circular economy industrial platform targeting the food and beverage, and pharmaceutical health industries[35]. - The company is actively planning for high-quality development during the "14th Five-Year Plan" period[35]. - The company has implemented a digital factory initiative to enhance management efficiency across production, operations, safety, and environmental protection[43]. - The company has expanded its supplier network to ensure stable material supply amid ongoing pandemic impacts and rising raw material prices[44].
金禾实业(002597) - 2022 Q1 - 季度财报
2022-04-28 16:00
Financial Performance - The company's operating revenue for Q1 2022 was CNY 1,898,030,890.31, representing a 66.91% increase compared to CNY 1,137,138,227.17 in the same period last year[4] - Net profit attributable to shareholders was CNY 441,869,520.27, up 110.21% from CNY 210,203,133.05 year-on-year[4] - The net profit margin improved significantly, with basic earnings per share rising to CNY 0.79, a 113.51% increase from CNY 0.37[4] - Total operating revenue for the first quarter reached ¥1,898,030,890.31, a significant increase of 67.0% compared to ¥1,137,138,227.17 in the previous year[27] - Net profit for the period was ¥441,785,771.93, representing a 110.7% increase from ¥209,907,357.27 year-over-year[30] Cash Flow - The net cash flow from operating activities reached CNY 211,462,032.98, a significant increase of 339.05% compared to CNY 48,163,328.45 in the previous year[4] - Cash inflow from operating activities totaled CNY 1,662,653,115.51, up from CNY 1,160,651,084.78 in the previous period[37] - The net cash flow from operating activities was CNY 211,462,032.98, compared to CNY 48,163,328.45 in the previous period, showing a substantial improvement[37] - Cash inflow from investment activities amounted to CNY 1,037,128,411.59, significantly higher than CNY 190,440,292.69 in the previous period[37] - The net cash flow from investment activities was negative at CNY -516,575,369.45, compared to CNY -464,130,746.87 in the previous period[37] - Cash inflow from financing activities was CNY 154,000,000.00, down from CNY 440,000,000.00 in the previous period[40] - The net increase in cash and cash equivalents was CNY -232,313,734.61, compared to CNY -85,819,521.89 in the previous period[40] - The ending balance of cash and cash equivalents stood at CNY 701,355,743.86, compared to CNY 480,208,473.00 in the previous period[40] Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 9,305,090,241.61, reflecting a 5.17% increase from CNY 8,847,824,127.36 at the end of the previous year[4] - The total assets at the end of the reporting period amount to ¥5,907,521,695.69, compared to ¥5,493,948,776.20 at the beginning of the year[20] - Total liabilities rose to ¥3,063,527,117.27, up from ¥3,006,706,635.33, indicating a 1.7% increase[26] - The equity attributable to shareholders of the parent company increased to ¥6,240,363,467.32, a rise of 6.8% from ¥5,840,834,086.67[26] Shareholder Information - The total number of common shareholders at the end of the reporting period is 26,254[12] - Anhui Jinrui Investment Group Co., Ltd. holds 44.66% of shares, totaling 250,487,223 shares, with 28,500,000 shares pledged[12] Investments and Expenses - Research and development expenses for the quarter were ¥44,734,648.37, an increase of 22.5% compared to ¥36,685,547.61 in the previous year[27] - Financial expenses decreased to ¥1,190,080.39 from ¥5,541,183.82, showing a reduction of 78.5%[30] - The company reported an investment income of ¥10,183,548.29, down from ¥35,467,761.46, indicating a decline of 71.2%[30] - Deferred income tax liabilities decreased to ¥19,568,713.20 from ¥25,395,571.04, a reduction of 22.9%[26] Other Key Developments - The company plans to continue expanding its production capacity and adjusting product prices in response to rising costs in the food additives and bulk chemicals sectors[8] - The company has completed a patent infringement investigation by the U.S. International Trade Commission, confirming no violations related to its sweetener products[17] - The company plans to repurchase shares with a budget between ¥75 million and ¥150 million, with a maximum repurchase price of ¥55.00 per share[17] - The company has repurchased 258,000 shares, representing 0.0460% of the total share capital, with a total transaction amount of ¥10,123,464.00[17] Audit Status - The report for the first quarter was not audited[41]
金禾实业(002597) - 2021 Q4 - 年度财报
2022-03-21 16:00
Financial Performance - The company reported a total revenue of 556,166,953, with a cash dividend of 6.50 yuan per 10 shares (including tax) for all shareholders[8]. - The company's operating revenue for 2021 was ¥5,845,322,601.18, representing a 59.44% increase compared to ¥3,666,246,520.47 in 2020[28]. - The net profit attributable to shareholders for 2021 was ¥1,177,102,453.70, a 63.82% increase from ¥718,525,167.63 in 2020[28]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥994,751,755.94, up 74.51% from ¥570,031,064.08 in 2020[28]. - The company's total assets at the end of 2021 were ¥8,847,824,127.36, an increase of 26.43% from ¥6,998,152,136.98 at the end of 2020[28]. - The basic earnings per share for 2021 were ¥2.10, a 62.79% increase compared to ¥1.29 in 2020[28]. - The weighted average return on equity for 2021 was 22.09%, up from 15.50% in 2020[28]. - The net cash flow from operating activities for 2021 was ¥884,916,187.25, a decrease of 10.97% from ¥994,007,247.99 in 2020[28]. - The company reported a significant increase in government subsidies, amounting to ¥40,663,568.00 in 2021 compared to ¥32,645,283.08 in 2020[34]. - The total operating revenue for the reporting period reached ¥5,845,322,601.18, representing a year-on-year increase of 59.44%[91]. - Revenue from the food manufacturing segment was ¥3,029,083,784.52, accounting for 51.82% of total revenue, with a year-on-year growth of 59.32%[91]. - The basic chemical segment generated ¥2,350,644,250.65 in revenue, making up 40.21% of total revenue, with a year-on-year increase of 53.70%[91]. Business Operations - The company has no changes in its main business since its listing, indicating stability in operations[26]. - The company has a total of 5 wholly-owned subsidiaries and 1 holding subsidiary, enhancing its operational capabilities[17]. - The company has not undergone any changes in its controlling shareholder, indicating stability in ownership[26]. - The company has maintained its registered address and contact information, ensuring consistency in communication[21][22]. - The company has engaged Rongcheng Accounting Firm for auditing, ensuring compliance with financial regulations[27]. - The company has a total of 2,597 stock code listed on the Shenzhen Stock Exchange, reflecting its market presence[21]. - The company operates two major chemical parks, producing basic chemicals and food additives in Chuzhou[65]. - The company has a food production license valid until April 13, 2026, covering various food additives and sweeteners[68]. - The company has a high-tech enterprise certificate valid until September 18, 2024, indicating its commitment to innovation[68]. Market Position and Strategy - The company is positioned in the food manufacturing industry, benefiting from the growing demand for low-sugar and no-sugar products driven by health trends and government policies[42]. - The chemical industry, where the company operates, is experiencing increased demand and rising prices due to new safety and environmental regulations, as well as the impact of the COVID-19 pandemic on supply chains[43]. - The company has established a strategic layout and product line targeting the food and beverage, pharmaceutical health, and other industries, supported by a well-developed circular economy and public engineering facilities[44]. - The company is focused on diversifying its product lines and enhancing its industrial capabilities in bulk chemicals and functional chemical products[72]. - The company is actively adjusting sales strategies for sweeteners like Acesulfame and Sucralose to mitigate rising costs due to increased raw material prices and shipping fees[84]. - The company is leveraging its location in Anhui Province, close to the Yangtze River Delta, to optimize logistics and resource access[75]. - The company is focusing on expanding its product line in the food additives and flavoring sectors, aiming for significant breakthroughs in technology and market presence[80]. - The company plans to enhance its R&D capabilities by focusing on key catalytic technologies and green synthesis technologies[148]. Research and Development - The company holds 12 patents related to the production technology of sucralose, 12 patents for aspartame, 15 patents for ethyl maltol, and 4 patents for hydrogen peroxide, all indicating a strong R&D capability[64]. - The company has established a technology center and a post-doctoral workstation, enhancing its technological innovation and talent development[72]. - The company has established a comprehensive R&D platform to enhance product application solutions and improve production efficiency[77]. - The company completed several key R&D projects aimed at improving product competitiveness and operational efficiency[116]. - The number of R&D personnel increased by 5.74% to 516, with the proportion of R&D personnel in the company rising to 11.68%[116]. - Research and development expenses increased by 51.88% to ¥182,871,407.48, driven by an increase in R&D personnel and rising raw material costs[112]. Risk Management and Compliance - The company emphasizes the importance of risk awareness regarding forward-looking statements made in the report[7]. - The company has a risk management strategy in place to address environmental governance and safety production risks[153]. - The company maintains a robust governance structure, ensuring compliance with legal and regulatory requirements, and has not faced any administrative penalties[166]. - The board of directors consists of nine members, including three independent directors, ensuring compliance with governance standards[166]. - The company emphasizes transparent communication with investors, adhering to information disclosure regulations and maintaining open channels for investor feedback[167]. - The company operates independently from its controlling shareholders, ensuring that decision-making processes are not influenced by external parties[170]. Future Outlook - The company provided a positive outlook for the next quarter, projecting a revenue growth of 10% to 12%[188]. - New product launches are expected to contribute an additional 200 million RMB in revenue over the next fiscal year[188]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million RMB for potential targets[188]. - The management team emphasized the importance of sustainability initiatives, aiming to reduce operational costs by 8% through eco-friendly practices[188]. - The company aims to increase its flagship products or product clusters to five by the end of 2022 and successfully expand into one or two new business sectors[147]. Compensation and Governance - Total compensation for senior management during the reporting period amounted to 933.33 million CNY[197]. - The highest compensation was received by the Vice Chairman and General Manager, totaling 88.91 million CNY[197]. - The Chairman received a total compensation of 78.18 million CNY, while the Deputy General Manager received 78.97 million CNY[197]. - Independent directors received a total compensation of 8.33 million CNY each[197]. - The financial director's compensation was reported at 29.26 million CNY[197]. - The average age of the board members is approximately 52 years[197]. - The company has a total of 15 board members, including independent directors and supervisors[198]. - All board members attended all five board meetings held during the reporting period[198].